Enzymatica AB Statistics

Total Valuation

Enzymatica AB has a market cap or net worth of SEK 767.04 million. The enterprise value is 702.31 million.

Market Cap	767.04M
Enterprise Value	702.31M

Important Dates

The next estimated earnings date is Thursday, July 17, 2025.

Earnings Date	Jul 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Enzymatica AB has 242.74 million shares outstanding. The number of shares has increased by 28.22% in one year.

Current Share Class	242.74M
Shares Outstanding	242.74M
Shares Change (YoY)	+28.22%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.07%
Owned by Institutions (%)	12.30%
Float	198.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.84
PB Ratio	4.86
P/TBV Ratio	8.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-13.42
EV / Sales	14.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.33

Financial Position

The company has a current ratio of 4.47, with a Debt / Equity ratio of 0.01.

Current Ratio	4.47
Quick Ratio	3.65
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.03
Interest Coverage	-33.68

Financial Efficiency

Return on equity (ROE) is -43.26% and return on invested capital (ROIC) is -23.75%.

Return on Equity (ROE)	-43.26%
Return on Assets (ROA)	-20.30%
Return on Invested Capital (ROIC)	-23.75%
Return on Capital Employed (ROCE)	-32.54%
Revenue Per Employee	2.31M
Profits Per Employee	-2.49M
Employee Count	21
Asset Turnover	0.30
Inventory Turnover	0.99

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +20.69% in the last 52 weeks. The beta is 0.21, so Enzymatica AB's price volatility has been lower than the market average.

Beta (5Y)	0.21
52-Week Price Change	+20.69%
50-Day Moving Average	3.57
200-Day Moving Average	2.26
Relative Strength Index (RSI)	55.39
Average Volume (20 Days)	64,640

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Enzymatica AB had revenue of SEK 48.43 million and -52.32 million in losses. Loss per share was -0.25.

Revenue	48.43M
Gross Profit	32.74M
Operating Income	-51.64M
Pretax Income	-52.40M
Net Income	-52.32M
EBITDA	-48.88M
EBIT	-51.64M
Loss Per Share	-0.25

Full Income Statement

Balance Sheet

The company has 66.62 million in cash and 1.88 million in debt, giving a net cash position of 64.73 million or 0.27 per share.

Cash & Cash Equivalents	66.62M
Total Debt	1.88M
Net Cash	64.73M
Net Cash Per Share	0.27
Equity (Book Value)	157.96M
Book Value Per Share	0.65
Working Capital	77.29M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -61.72 million and capital expenditures -273,000, giving a free cash flow of -61.99 million.

Operating Cash Flow	-61.72M
Capital Expenditures	-273,000
Free Cash Flow	-61.99M
FCF Per Share	-0.26

Full Cash Flow Statement

Margins

Gross margin is 67.59%, with operating and profit margins of -106.62% and -108.03%.

Gross Margin	67.59%
Operating Margin	-106.62%
Pretax Margin	-108.19%
Profit Margin	-108.03%
EBITDA Margin	-100.92%
EBIT Margin	-106.62%
FCF Margin	n/a

Dividends & Yields

Enzymatica AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-28.22%
Shareholder Yield	-28.22%
Earnings Yield	-6.82%
FCF Yield	-8.08%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a